Actively Recruiting
Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants
Led by University Hospital, Basel, Switzerland · Updated on 2025-03-27
24
Participants Needed
1
Research Sites
69 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objective of this study is to determine whether equivalent moderately high doses of LSD, psilocybin, and DMT produce qualitatively similar peak effects when the effect duration is standardized with ketanserin. A DMT infusion mimicking oral LSD and psilocybin administrations will be tested, as well as intravenously administered ketanserin.
CONDITIONS
Official Title
Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Good understanding of the German language
- Understanding of procedures and risks associated with the study
- Willing to adhere to the protocol and signing of the consent form
- Willing to refrain from the consumption of illicit psychoactive substances during the study
- Willing not to operate heavy machinery within 48 h after administration of a study substance
- Willing to use effective birth control throughout study participation
- Body mass index 17 - 34.9 kg/m2
You will not qualify if you...
- Relevant chronic or acute medical condition
- Current or previous major psychiatric disorder (e.g. psychotic disorder)
- Psychotic disorder or bipolar disorder in first-degree relatives
- Hypertension (SBP>140/90 mmHg) or hypotension (SBP<85 mmHg)
- Bradycardia (< 45 bpm)
- Prolonged QTc interval (males: >450 ms, females: >470 ms)
- AV block II° (Mobitz type and Webckebach type) and III°
- Hallucinogenic substance use (not including cannabis) more than 20 times or any time within the previous two months
- Pregnancy or current breastfeeding
- Participation in another clinical trial (currently or within the last 30 days)
- Use of medication that may interfere with the effects of the study medication
- Tobacco smoking (>10 cigarettes/day)
- Excessive consumption of alcoholic beverages (>15 drinks/week)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital
Basel, Switzerland, 4056
Actively Recruiting
Research Team
M
Matthias E Liechti, Prof. Dr. MD
CONTACT
M
Mélusine Humbert-Droz, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here